Literature DB >> 20622942

The dopamine dilemma: using stimulants and antipsychotics concurrently.

Jason Yanofski1.   

Abstract

Stimulant and antipsychotic medications are commonly used together without concern, despite their potentially opposing mechanisms. An examination of dopamine pathways and receptors suggests that concerns regarding interactions between these two classes are justified and relevant. Efficacy of concurrent use is reviewed for several indications, with a focus on comorbid attention deficit hyperactivity disorder and aggression. The risk of adverse reactions is examined. Complex dopamine mechanisms are considered to explain the dilemma, and general treatment guidelines for stimulant-antipsychotic concurrent use are discussed.

Entities:  

Keywords:  ADHD; antipsychotics; children; dopamine; dyskinesias; psychotropic medications; stimulants; tics

Year:  2010        PMID: 20622942      PMCID: PMC2898838     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  60 in total

Review 1.  Clinical practice. Attention deficit-hyperactivity disorder.

Authors:  Marsha D Rappley
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

2.  Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity.

Authors:  A Weizman; R Weitz; G A Szekely; S Tyano; R H Belmaker
Journal:  J Am Acad Child Psychiatry       Date:  1984-05

3.  Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings.

Authors:  K D Gadow; E E Nolan; J Sverd; J Sprafkin; L Paolicelli
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1990-09       Impact factor: 8.829

4.  Trends in the prescribing of psychotropic medications to preschoolers.

Authors:  J M Zito; D J Safer; S dosReis; J F Gardner; M Boles; F Lynch
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 5.  The use of atypical antipsychotics in pediatric bipolar disorder.

Authors:  Kiki D Chang
Journal:  J Clin Psychiatry       Date:  2008       Impact factor: 4.384

Review 6.  Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.

Authors:  Robert L Findling
Journal:  J Clin Psychiatry       Date:  2008       Impact factor: 4.384

7.  Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.

Authors:  D F Connor; S Benjamin; K R Ozbayrak
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-11       Impact factor: 8.829

8.  Characterization of methylphenidate self-administration and reinstatement in the rat.

Authors:  Leigh C P Botly; Christie L Burton; Zoë Rizos; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2008-05-16       Impact factor: 4.530

Review 9.  The Yin and Yang of dopamine release: a new perspective.

Authors:  Yukiori Goto; Satoru Otani; Anthony A Grace
Journal:  Neuropharmacology       Date:  2007-07-19       Impact factor: 5.250

Review 10.  Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder.

Authors:  Sverker Sikström; Göran Söderlund
Journal:  Psychol Rev       Date:  2007-10       Impact factor: 8.934

View more
  16 in total

1.  Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.

Authors:  L J S Schweren; C A Hartman; M P Zwiers; D J Heslenfeld; D van der Meer; B Franke; J Oosterlaan; J K Buitelaar; P J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-14       Impact factor: 4.785

2.  Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps.

Authors:  Regina Bussing; Almut G Winterstein
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 3.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

4.  The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?

Authors:  Jason Yanofski
Journal:  Innov Clin Neurosci       Date:  2011-01

5.  Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more.

Authors:  Ahmed Naguy
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

6.  Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.

Authors:  Dean Elbe; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

7.  Managing the comorbidity of schizophrenia and ADHD.

Authors:  Amy Gough; Jason Morrison
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

8.  Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.

Authors:  Dominik Stämpfli; Stefan Weiler; Andrea M Burden
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-03       Impact factor: 4.785

9.  Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.

Authors:  Mohamed Mohamoud; Qi Chen; David Croteau; Carmen Cheng; Keith Burkhart; Donna A Volpe; Cindy Kortepeter; Dorothy Demczar; Marc Stone
Journal:  J Clin Psychopharmacol       Date:  2022 May-Jun 01       Impact factor: 3.118

Review 10.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.